Human papillomavirus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year. Unlike cervical ...

Human papilloma virus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year. Unlike cervical ...

A blood test based on whole-genome sequencing achieved 99% sensitivity and specificity for detecting HPV-positive head and neck cancer. Early postoperative detection of circulating tumor DNA predicted ...

The Madhya Pradesh government has signed a Memorandum of Understanding (MoU) with Hyderabad-based private firm to strengthen ...

The American Society for Colposcopy and Cervical Pathology (ASCCP) has issued new guidelines reflecting the importance of extended genotyping in HPV testing to support an enhanced standard of patient ...

A team of researchers led by Rice University, in collaboration with colleagues in Mozambique and The University of Texas MD Anderson Cancer Center, has developed a simple, affordable human ...

A team of Rice University bioengineers has developed a new way to create highly realistic "mock" patient samples that could ...

Mel-Mont Medical, a women's health diagnostics company advancing accessible cervical cancer screening through HPV-positive patient risk assessment, announced today that it was recognized at the 2026 ...

A groundbreaking blood test, HPV-DeepSeek, developed by Mass General Brigham researchers, offers early detection of HPV-associated head and neck cancers, potentially up to a decade before symptoms ...